1. Home
  2. STOK vs PSBD Comparison

STOK vs PSBD Comparison

Compare STOK & PSBD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • STOK
  • PSBD
  • Stock Information
  • Founded
  • STOK 2014
  • PSBD 2009
  • Country
  • STOK United States
  • PSBD United States
  • Employees
  • STOK N/A
  • PSBD N/A
  • Industry
  • STOK Biotechnology: Pharmaceutical Preparations
  • PSBD
  • Sector
  • STOK Health Care
  • PSBD
  • Exchange
  • STOK Nasdaq
  • PSBD Nasdaq
  • Market Cap
  • STOK 556.7M
  • PSBD 507.0M
  • IPO Year
  • STOK 2019
  • PSBD 2024
  • Fundamental
  • Price
  • STOK $8.33
  • PSBD $15.30
  • Analyst Decision
  • STOK Strong Buy
  • PSBD Buy
  • Analyst Count
  • STOK 8
  • PSBD 7
  • Target Price
  • STOK $23.83
  • PSBD $16.93
  • AVG Volume (30 Days)
  • STOK 830.1K
  • PSBD 19.0K
  • Earning Date
  • STOK 03-24-2025
  • PSBD 03-03-2025
  • Dividend Yield
  • STOK N/A
  • PSBD 12.44%
  • EPS Growth
  • STOK N/A
  • PSBD N/A
  • EPS
  • STOK N/A
  • PSBD N/A
  • Revenue
  • STOK $16,742,999.00
  • PSBD N/A
  • Revenue This Year
  • STOK $105.42
  • PSBD N/A
  • Revenue Next Year
  • STOK $15.13
  • PSBD N/A
  • P/E Ratio
  • STOK N/A
  • PSBD N/A
  • Revenue Growth
  • STOK 81.08
  • PSBD N/A
  • 52 Week Low
  • STOK $5.28
  • PSBD $15.12
  • 52 Week High
  • STOK $17.58
  • PSBD $17.09
  • Technical
  • Relative Strength Index (RSI)
  • STOK 32.00
  • PSBD 41.31
  • Support Level
  • STOK $9.76
  • PSBD $15.30
  • Resistance Level
  • STOK $11.11
  • PSBD $15.74
  • Average True Range (ATR)
  • STOK 0.88
  • PSBD 0.35
  • MACD
  • STOK -0.30
  • PSBD -0.04
  • Stochastic Oscillator
  • STOK 2.31
  • PSBD 2.60

About STOK Stoke Therapeutics Inc.

Stoke Therapeutics Inc is engaged in addressing the underlying causes of severe diseases by upregulating protein expression with RNA-based medicines. Using its proprietary TANGO (Targeted Augmentation of Nuclear Gene Output) approach, it is developing antisense oligonucleotides (ASOs) to selectively restore protein levels. Its first compound, STK-001, is in clinical testing for the treatment of Dravet syndrome, a severe and progressive genetic epilepsy. The company primarily operates in the U.S.

About PSBD Palmer Square Capital BDC Inc.

Palmer Square Capital BDC Inc is a financial services company that lends to and invests in corporate debt securities of companies, including small to large private U.S. companies. Their investment objective is to maximize total return, comprised of current income and capital appreciation.

Share on Social Networks: